18.93
+0.3(+1.61%)
Currency In USD
| Previous Close | 18.63 |
| Open | 18.7 |
| Day High | 19.01 |
| Day Low | 18.6 |
| 52-Week High | 32.75 |
| 52-Week Low | 10.01 |
| Volume | 99,519 |
| Average Volume | 395,250 |
| Market Cap | 684.19M |
| PE | -15.14 |
| EPS | -1.25 |
| Moving Average 50 Days | 17.32 |
| Moving Average 200 Days | 21.94 |
| Change | 0.3 |
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
GlobeNewswire Inc.
May 20, 2025 8:05 PM GMT
SUNNYVALE, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
GlobeNewswire Inc.
Apr 30, 2025 8:05 PM GMT
SUNNYVALE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced th
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
GlobeNewswire Inc.
Apr 30, 2025 12:00 PM GMT
Ceribell is one of only 51 companies in the U.S. to achieve FedRAMP High authorization Ceribell's breakthrough technology can now be deployed in federal healthcare facilities, including U.S. Department of Veterans Affairs hospitals, helping clinician